Unraveling HIV protease flaps dynamics by Constant pH Molecular Dynamics simulations

J Struct Biol. 2016 Aug;195(2):216-226. doi: 10.1016/j.jsb.2016.06.006. Epub 2016 Jun 10.

Abstract

The active site of HIV protease (HIV-PR) is covered by two flaps. These flaps are known to be essential for the catalytic activity of the HIV-PR, but their exact conformations at the different stages of the enzymatic pathway remain subject to debate. Understanding the correct functional dynamics of the flaps might aid the development of new HIV-PR inhibitors. It is known that, the HIV-PR catalytic efficiency is pH-dependent, likely due to the influence of processes such as charge transfer and protonation/deprotonation of ionizable residues. Several Molecular Dynamics (MD) simulations have reported information about the HIV-PR flaps. However, in MD simulations the protonation of a residue is fixed and thus it is not possible to study the correlation between conformation and protonation state. To address this shortcoming, this work attempts to capture, through Constant pH Molecular Dynamics (CpHMD), the conformations of the apo, substrate-bound and inhibitor-bound HIV-PR, which differ drastically in their flap arrangements. The results show that the HIV-PR flaps conformations are defined by the protonation of the catalytic residues Asp25/Asp25' and that these residues are sensitive to pH changes. This study suggests that the catalytic aspartates can modulate the opening of the active site and substrate binding.

Keywords: Constant pH Molecular Dynamics; Flaps; HIV protease; Protein conformation; pH.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aspartic Acid / chemistry*
  • Binding Sites
  • Catalysis*
  • Catalytic Domain
  • HIV / chemistry*
  • HIV Protease / chemistry*
  • HIV Protease Inhibitors / chemistry*
  • Hydrogen Bonding
  • Hydrogen-Ion Concentration
  • Molecular Dynamics Simulation
  • Protein Binding
  • Protein Conformation
  • Substrate Specificity

Substances

  • HIV Protease Inhibitors
  • Aspartic Acid
  • HIV Protease